Login Start free

Focus

Drug Discovery Investors: Angels and VC Firms

The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.

Strongest in New York, San Francisco and Boston

Common stages: Seed and Series A

4,683: Drug Discovery investors
239: Angel investors
4,444: People at VC/PE firms
1,313: Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

4,683 Drug Discovery investors

Showing 141-160

Filters

Viewing

Drug Discovery4,683

Investor Type

Choosing one replaces Drug Discovery.

Investment Stage

Choosing one replaces Drug Discovery.

Seed84,745
Series A53,997
Late-Stage37,937
Series B35,865
Growth34,738
Pre-Seed32,477

Investment Profile

Choosing one replaces Drug Discovery.

SaaS63,483
FinTech54,183
Healthcare53,462
Consumer46,735
AI46,189
Hardware36,507
Commerce32,773
Climate23,313
Real Estate17,905
Education13,608
Food10,848
Travel7,450
Energy946
Agriculture555

Country

Choosing one replaces Drug Discovery.

City

Choosing one replaces Drug Discovery.

Focus1

Investor	Location	Type	Markets	Contact	Actions
Karthik Narayanaswamy Partner & Head of India at Novo Holdings	Mumbai, India	Family OfficePrivate equity	FinTechHardware		View profile
Karen Spilizewski Managing Director at RiverVest Venture Partners	Cleveland, United States	Venture capital	HardwareHealthcare		View profile
Mara Macdonald Investment Manager at Brandon Capital	Melbourne, Australia	Venture capital	Healthcare		View profile
Jennifer Williams Partner and CFO at Genesys Capital	Toronto, Canada	Corporate VCVenture capital	AIHealthcare		View profile
Kevin Kinsella Investor at Avalon Partners	San Diego, United States	Venture capital	AIConsumer		View profile
Clay Maxwell Angel Investor at Duke Capital Partners	San Francisco, United States	AcceleratorSyndicate / Angel group	AIHardware		View profile
Daniel Bahcheli Director at RA Capital Management	Boston, United States	Private equityVenture capital	FinTechHealthcare		View profile
Maja Markovic Partner at Gimv	Munich, Germany	Private equity	ClimateFood		View profile
Valentina Agostoni Principal at TVM Capital Life Science	Montreal, Canada	Venture capital	ConsumerHardware		View profile
Zhaopei Liu Bioventure Associate at Hillhouse Investment	Beijing, China	Private equityVenture capital	AIClimate		View profile
Tom Masterson Investor at Allele Capital Partners	Fort Lauderdale, United States	Private equityVenture debt	Healthcare		View profile
Brian Chee Managing Partner at Polaris Partners	San Francisco, United States	Venture capital	AIHealthcare		View profile
Stefan Fischer Managing Partner (Finance) bei TVM Capital Life Science at TVM Capital Life Science	Munich, Germany	Venture capital	ConsumerHardware		View profile
Matthew Hammond Partner at RA Capital Management	Boston, United States	Private equityVenture capital	FinTechHealthcare		View profile
Jack Slaughter Principal at Mountain Group Partners	Nashville, United States	Private equityVenture capital	ClimateConsumer		View profile
Aaron Jacobson Director at Juvo Ventures	San Francisco, United States	Venture capital	AICommerce		View profile
Kevin Bitterman Partner at Atlas Venture	Cambridge, United States	Venture capital	CommerceConsumer		View profile
Minglin Ma Executive Director at Vertex Pharmaceuticals	Ithaca, United States	Corporate VCFamily Office	AIClimate		View profile
Heather Preston General Partner at Oxonian Ventures	San Francisco, United States	Private equityVenture capital	AIConsumer		View profile
George Petrocheilos Co-Founder & Managing Partner at Catalio Capital Management	New York, United States	Venture capitalVenture debt	AIHealthcare		View profile

Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal